ESC 365 - Clinical outcomes after early vs new generation TAVR device deployment

ESC Premium Access

Clinical outcomes after early vs new generation TAVR device deployment

Session: Poster Session 4 - Structural percutaneous intervention

Topic: Aortic Valve Intervention

Speaker: Doctor L. Kalinczuk (Warsaw, PL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Lukasz Kalinczuk

Institute of Cardiology, Warsaw (Poland)

0 follower

8 more presentations in this session

Incidence of bicuspid aortic valve in 16,185 neonates by echocardiographic screening in a single institution: is it really congenial?

Speaker: Doctor K. Waki (Kurashiki, JP)

Predictors of access site complication in transfemoral transcatheter aortic valve implantation

Speaker: Doctor M. Potratz (Bad Oeynhausen, DE)

Predictors, feasibility and outcomes of coronary interventions up to 3 years after TAVI with a balloon-expandable valve. Results from a large European multicenter registry.

Speaker: Associate Professor G. Tarantini (Padova, IT)

Differences in short-term outcome between balloon- and self-expandable TAVR devices relating to more than one generation.

Speaker: Assistant Professor V. Veulemans (Duesseldorf, DE)

Incidence and outcomes of delirium in patients undergoing transcatheter aortic valve replacement.

Speaker: Doctor T. Luque Diaz (Madrid, ES)

Access the full session

Poster Session 4 - Structural percutaneous intervention

Speakers: Doctor L. Kalinczuk, Doctor K. Waki, Doctor M. Potratz, Associate Professor G. Tarantini, Assistant Professor V. Veulemans...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources